As of April 2024 CymaBay Therapeutics has a market cap of $3.72 Billion. This makes CymaBay Therapeutics the world's 3039th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $3.72 B | 39.19% |
2023 | $2.67 B | 404.49% |
2022 | $0.53 B | 85.53% |
2021 | $0.28 B | -27.62% |
2020 | $0.39 B | 192.88% |
2019 | $0.13 B | -71.15% |
2018 | $0.46 B | 15.95% |
2017 | $0.40 B | 894.86% |
2016 | $40.56 M | 2.37% |
2015 | $39.62 M | -72.57% |
2014 | $0.14 B |
On Apr 19th, 2024 the market cap of CymaBay Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $147.22 B | 3,848.97% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.16 B | 2,559.97% | ๐บ๐ธ USA |
Xencor XNCR | $1.12 B | -69.87% | ๐บ๐ธ USA |
PTC Therapeutics
PTCT | $1.93 B | -47.97% | ๐บ๐ธ USA |